There is decreased risk for MACE and all-cause mortality in dialysis-dependent patients with ASCVD who are treated with statins.

Ultragenyx Pharmaceutical RARE reported second-quarter 2025 loss of $1.17 per share, narrower than the Zacks Consensus ...

The FDA has approved a labeling update for Leqvio (inclisiran) allowing for first-line use in the treatment of hypercholesterolemia.

A top U.S. cardiologist says doctors are "underdosing" high-potency statins to patients who have high levels of "bad" ...

This cost-effectiveness analysis demonstrated that the PRS could guide statin therapy for greater quality-adjusted life expectancy for an intermediate risk population.

AURKB regulates cholesterol ester hydrolysis, elevates tumour cholesterol levels and inhibits T cell function. Targeting AURKB or reducing tumour cholesterol could offer a strategy to treat CCA and ...

Potent statins are the best-proven weapon against heart disease, especially when paired with lifestyle changes. Most people aren’t active enough—and many are underdiagnosed—so starting treatment ...

There is broad consensus that the overall body of evidence shows lowering LDL (low-density lipoprotein) cholesterol provides ...

Democrats' grocery chart backfires, revealing truth about inflation under Biden vs Trump.

Coronary artery calcium scans can offer a more precise estimate of a patient’s chances for major cardiac events. Some cardiologists say it remains underused.

ABC News' Dr. Tara Narula explains why some people are hesitant to take statins, which may be recommended when lifestyle changes aren't enough to lower LDL cholesterol.

Should you take a statin? What to know ABC News' Dr. Tara Narula explains why some people are hesitant to take statins, which may be recommended when lifestyle changes aren't enough to lower LDL ...